(Q38367776)

2 September 2017

1 reference

title

Hyperuricemia, gout, and cardiovascular disease: an update (English)

1 reference

2 September 2017

cardiovascular disease

1 reference

Aryeh M Abeles

1

1 reference

2 September 2017

1 March 2015

1 reference

Current Rheumatology Reports

2 September 2017

1 reference

2 September 2017

17

1 reference

2 September 2017

3

1 reference

2 September 2017

13

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-015-0495-2

2 September 2017

0 references

cites work

Prevalence of contraindications and prescription of pharmacologic therapies for gout.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Comorbidities in patients with gout prior to and following diagnosis: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Can animal models of disease reliably inform human studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Serum urate association with hypertension in young adults: analysis from the Coronary Artery Risk Development in Young Adults cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Plasma uric acid level and risk for incident hypertension among men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Cardiovascular risk factors and comorbidities in patients with hyperuricemia and/or gout: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Allopurinol on hypertension: insufficient evidence to recommend.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Does decreasing serum uric acid level prevent hypertension? - a nested RCT in cohort study: rationale, methods, and baseline characteristics of study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Serum uric acid level and risk for peripheral arterial disease: analysis of data from the multiple risk factor intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Treatment of asymptomatic hyperuricemia for the prevention of gouty arthritis, renal disease, and cardiovascular events: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Gout and the risk of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Risk of myocardial infarction among patients with gout: a nationwide population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Long-term cardiovascular mortality among middle-aged men with gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-015-0495-2

Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.

21 January 2018

1 reference

12 December 2020

Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008.

1 reference

12 December 2020

Independent impact of gout on mortality and risk for coronary heart disease

1 reference

12 December 2020

Uric acid concentration as a risk marker for blood pressure progression and incident hypertension: a Chinese cohort study

1 reference

12 December 2020

Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries

1 reference

12 December 2020

Pharmacotherapy for hyperuricemia in hypertensive patients

1 reference

12 December 2020

Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink

1 reference

12 December 2020

Impact of allopurinol on risk of myocardial infarction

1 reference

12 December 2020

Hypertension and hyperuricaemia.

1 reference

12 December 2020

Uric acid and cardiovascular risk

1 reference

12 December 2020

Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies

1 reference

12 December 2020

Hyperuricemia in primary and renal hypertension

1 reference

12 December 2020

Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008

1 reference

12 December 2020

10.1007/S11926-015-0495-2

Identifiers

DOI

1 reference

PubMed ID

25740704

Dimensions Publication ID

2 September 2017

0 references

1 reference

PubMed ID

25740704